August 21, 2026
GeneCentric
GeneCentric closed an initial $8 million Series C round to support the launch of its GenomicsNext Liquid Biopsy Platform.
- Round
- Series C
- Amount raised
- $8M
- Lead investor
- —
- Industry
- Biotechnology, Genomics
- Headquarters
- United States
- Employees
- 11-50 employees
- Website
- genecentric.com
- View profile →
Source: Eli Lilly Joins Leal Therapeutics $30M Series A Extension Round